Humira pen 40 MG/0.8 MLS
Ended Awarded
- Contract number
- SPE2DB25FQ1YQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,115
Award facts
- Contract value 100% obligated
- $17,115.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,115.36 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of HUMIRA Pen 40 mg/0.8 mL injectable medication. This contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. As a child order, this award leverages AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical supply vehicle that runs through December 2026 and supports military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through the DLA Medical Supply Chain. The company's extensive portfolio encompasses brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. This particular delivery order for HUMIRA, a specialty immunosuppressant medication used in rheumatoid arthritis treatment, reflects the company's role in supplying specialized pharmaceuticals to support Defense Health Agency and other federal healthcare beneficiaries. The firm fixed pricing and competitive award history demonstrate AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements efficiently and cost-effectively.
Quick answers
Who was awarded contract SPE2DB25FQ1YQ?
SPE2DB25FQ1YQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 24, 2025.
How much is contract SPE2DB25FQ1YQ worth?
The government has obligated $17,115 on SPE2DB25FQ1YQ.
Is contract SPE2DB25FQ1YQ an order under another contract?
Yes. SPE2DB25FQ1YQ is a delivery order under SPE2DB22D3011, an indefinite delivery contract.
Was contract SPE2DB25FQ1YQ competed?
The extent of competition for SPE2DB25FQ1YQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award